US Stock MarketDetailed Quotes
PRTG Portage Biotech
- 6.000
- +3.300+122.20%
Close Aug 23 16:00 ET
- 5.760
- -0.240-4.00%
Post 19:59 ET
6.29MMarket Cap-77P/E (TTM)
8.280High3.900Low49.67MVolume4.250Open2.700Pre Close317.21MTurnover8358.59%Turnover RatioLossP/E (Static)1.05MShares61.98852wk High1.56P/B3.57MFloat Cap2.08052wk Low--Dividend TTM594.23KShs Float899.526Historical High--Div YieldTTM162.20%Amplitude2.080Historical Low6.386Avg Price1Lot Size
About Portage Biotech Company
Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.
Company Profile
SymbolPRTG
Company NamePortage Biotech
Listing DateFeb 25, 2021
Founded1973
CEODr. Ian B. Walters, M.D.
MarketNASDAQ
Employees7
Fiscal Year Ends03-31
AddressClarence Thomas Building
CityRoad Town
ProvinceTortola
CountryVirgin Islands (British)
Zip CodeVG1110
Phone1-203-221-7378
Company Executives
- Name
- Position
- Salary
- Dr. Ian B. Walters, M.D.
- Chief Executive Officer and Chairman of the Board
- 642.70K
- Brian Wiley
- Chief Business Officer
- 155.42K
- Allan Lee Shaw
- Chief Financial Officer
- 518.21K
- Robert Kramer
- Chief Scientific Officer
- 185.89K
- Dr. Justin Stebbing
- Director
- --
- Dr. Jean-Christophe Renondin, M.D.
- Director
- --
- Dr. Gregory Hugh Bailey, M.D.
- Lead Independent Director
- 103.98K
- James Mellon
- Independent Director
- 86.98K
- Steven M. Mintz
- Independent Director
- 96.48K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
